Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sol-Gel Technologies Ltd. - Ordinary Shares
(NQ:
SLGL
)
44.54
+2.69 (+6.43%)
Streaming Delayed Price
Updated: 3:59 PM EST, Dec 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sol-Gel Technologies Ltd. - Ordinary Shares
< Previous
1
2
Next >
12 Health Care Stocks Moving In Friday's Intraday Session
↗
November 07, 2025
Via
Benzinga
Booking Holdings To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday
↗
October 27, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
August 22, 2025
Via
Benzinga
Sol-Gel Stock Tumbles Over Underwhelming Q1 Earnings: Retail Stays Pessimistic
↗
May 23, 2025
The company’s diluted loss per share came in at $3.2, exceeding an estimated loss of $1.2.
Via
Stocktwits
Topics
Government
Sol-Gel Technologies: Q4 Earnings Insights
↗
March 13, 2024
Via
Benzinga
Recap: Sol-Gel Technologies Q3 Earnings
↗
November 09, 2023
Via
Benzinga
Expert Ratings for Sol-Gel Technologies
↗
August 11, 2023
Via
Benzinga
Sol-Gel Technologies: Q1 Earnings Insights
↗
May 13, 2022
Sol-Gel Technologies (NASDAQ:SLGL) reported its Q1 earnings results on Friday, May 13, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
US Stocks Gain, Nasdaq Surges Over 100 Points
↗
December 24, 2024
Via
Benzinga
Why Carbon Revolution Shares Are Trading Higher By Around 62%; Here Are 20 Stocks Moving Premarket
↗
December 24, 2024
Via
Benzinga
SLGL Stock Earnings: Sol-Gel Technologies Beats EPS, Beats Revenue for Q2 2024
↗
August 16, 2024
SLGL stock results show that Sol-Gel Technologies beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
SLGL Stock Earnings: Sol-Gel Technologies Misses EPS, Misses Revenue for Q1 2024
↗
May 20, 2024
SLGL stock results show that Sol-Gel Technologies missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Week in Review: Takeda Options Alzheimer's Therapy From AC Immune In $2.2 Billion Deal
↗
May 19, 2024
In the headline deal, Takeda acquires global rights from AC Immune of Switzerland for $100 million upfront and up to $2.1B in milestones.
Via
Talk Markets
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
July 25, 2024
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
September 29, 2023
Friday's session saw 112 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
October 05, 2023
On Thursday, 369 companies hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
September 26, 2023
On Tuesday, 386 stocks made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
September 15, 2023
Friday's session saw 169 companies set new 52-week lows.
Via
Benzinga
Sol-Gel Technologies Ltd. (NASDAQ: SLGL) Making Surprising Moves in Wednesday Session
March 22, 2023
Via
Investor Brand Network
7 Biotech Stocks That Could Be the Next Big Thing
↗
March 15, 2023
Although speculation might be a tough call at this juncture, these biotech stocks and their underlying science might be compelling enough.
Via
InvestorPlace
Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
March 22, 2023
Gainers Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) shares jumped 69.6% to $15.01 after dropping 24% on Tuesday.
Via
Benzinga
The Top 7 Penny Stocks to Invest in for the Long-Term
↗
February 23, 2023
Although penny stocks represent extremely high risks, a select few ideas could make for enticing long-term propositions.
Via
InvestorPlace
Heska To $165? Plus BTIG Cuts PT On This Stock By 67%
↗
November 14, 2022
BTIG cut the price target on Gain Therapeutics, Inc. (NASDAQ: GANX) from $30 to $10. BTIG analyst Thomas Shrader maintained a Buy rating on the stock. Gain Therapeutics shares rose 1.3% to close at...
Via
Benzinga
What Does Sunshine Biopharma's Acquisition Of Nora Pharma Mean For The Generic Prescription Drugs Market?
↗
November 07, 2022
The generic drug market has been growing since 1984 when the Hatch-Waxman Act encouraged manufacturing generics and developed a framework to regulate them.
Via
Benzinga
Nasdaq Turns Higher; Applied Genetic Technologies Shares Surge
↗
October 24, 2022
U.S. stocks traded mostly higher midway through trading, with the Dow Jones surging more than 300 points on Monday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022
↗
October 21, 2022
Upgrades
Via
Benzinga
Why Bank Stocks Traded Sharply Higher; Here's 65 Biggest Movers From Friday
↗
July 18, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering...
Via
Benzinga
Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session
↗
June 29, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 207% to $0.3650 after the company announced it has terminated its previously announced at-the-market offering.
Via
Benzinga
Citigroup, Bank of America And 48 Stocks Moving In Friday's Mid-Day Session
↗
July 15, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) shares jumped 180.9% to $6.19. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday.
Via
Benzinga
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
↗
November 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Commences Late-Stage Study Of Heart Failure Treatment Merck &...
Via
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
